October 28, 2014 by Brad Perriello
Nevro Corp. sets the per-share price range for its pending initial public offering, which would raise more than $106 million at the high end.
Nevro Corp. set the price range for its forthcoming initial public offering, which would raise $106.3 million at the high end of the range.
Menlo Park, Calif.-based Nevro plans to trade on the NASDAQ exchange under the symbol NVRO, according to a regulatory filing.
Nevro makes an implantable spinal cord stimulation system designed to treat chronic pain it calls Senza. Yesterday the company said it would issue 6.25 million shares at $15 to $17 apiece in the IPO, 1st announced earlier this month. That would mean proceeds of between $93.8 million and $106.3 million, or $100 million at the midpoint of the range.
